Published in Gastroenterology on June 01, 1977
Is mitochondrial antibody diagnostic of primary biliary cirrhosis? Gut (1981) 1.50
Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut (2004) 1.31
Are increased individual susceptibility and environmental factors both necessary for the development of primary biliary cirrhosis? Br Med J (1979) 1.03
Increased incidence of menstrual abnormalities and hysterectomy preceding primary biliary cirrhosis. Br Med J (Clin Res Ed) (1986) 1.02
Primary biliary cirrhosis: new perspectives in diagnosis and treatment. Postgrad Med J (2000) 0.82
Results of portal decompression in patients with primary biliary cirrhosis. Gut (1981) 0.77
The natural history of primary biliary cirrhosis. Trans Am Clin Climatol Assoc (1992) 0.75
Primary biliary cirrhosis: new perspectives. Trans Am Clin Climatol Assoc (1989) 0.75
Primary biliary cirrhosis presenting as pyrexia of unknown origin. J R Soc Med (1983) 0.75
Jaundice, hepatosplenomegaly and liver failure in a 60-year-old woman. West J Med (1981) 0.75
Morbidity and mortality of portal hypertension. Drugs (1989) 0.75
Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol (1966) 8.26
Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology (1994) 7.89
The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med (1973) 6.65
A classification of chronic hepatitis. Lancet (1968) 6.07
Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet (1972) 5.17
Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut (1980) 4.09
A randomised prospective comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding after acute dysphagic stroke. BMJ (1996) 3.83
Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med (1971) 3.23
Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ (1992) 3.17
Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet (1968) 3.10
A controlled trial of D-penicillamine therapy in primary biliary cirrhosis. Lancet (1977) 2.90
The epidemiology of testicular cancer in young adults. Am J Epidemiol (1980) 2.90
The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med (1979) 2.84
Spread of acute type-B hepatitis in London. Lancet (1973) 2.82
Measurement of liver-iron concentration in needle-biopsy specimens. Lancet (1971) 2.65
Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med (1966) 2.65
Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol (1984) 2.63
Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury. Lancet (1971) 2.61
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet (1970) 2.60
Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology (1975) 2.58
Partial nodular transformation of the liver with portal hypertension. Am J Med (1966) 2.45
Cell-mediated immunity in patients positive for hepatitis-associated antigen. Br Med J (1972) 2.39
Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J Pediatr (1993) 2.32
A randomized trial of percutaneous transhepatic cholangiography with the Chiba needle versus endoscopic retrograde cholangiography for bile duct visualization in jaundice. Gastroenterology (1976) 2.25
Prospective survey of investigations in outpatients referred with iron deficiency anaemia. Gut (1993) 2.21
Diagnosis of Gilbert's syndrome: role of reduced caloric intake test. Br Med J (1973) 2.21
Impaired delayed hypersensitivity in primary biliary cirrhosis. Lancet (1969) 2.19
Is primary biliary cirrhosis an immune complex disease? Lancet (1977) 2.15
The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol (1978) 2.13
The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology (1982) 2.11
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Complications of diuretic therapy in hepatic cirrhosis. Lancet (1966) 2.09
The endoscopic appearance of duodenal folds is predictive of untreated adult celiac disease. Gastrointest Endosc (1992) 2.01
Hereditary spherocytosis with secondary haemochromatosis. Lancet (1968) 2.00
Immune complexes in acute and chronic liver disease. Clin Exp Immunol (1978) 1.93
The pathology of hepatitis C. Hepatology (1992) 1.92
Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease. Lancet (1975) 1.90
Sex-related differences among 100 patients with alcoholic liver disease. Br Med J (1977) 1.89
Induction of remission in hepatocellular carcinoma with doxorubicin. Lancet (1978) 1.86
Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol (1993) 1.84
Hepatitis-associated antigen in chronic liver disease. Lancet (1969) 1.82
Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (1979) 1.81
Association of primary sclerosing cholangitis with HLA-B8. Gut (1983) 1.79
Hemolytic anemia in Wilson's disease. N Engl J Med (1967) 1.78
Hepatitis C virus transmitted by human bite. Lancet (1990) 1.77
8-Hydroxymanzamine A, a beta-carboline alkaloid from a sponge, Pachypellina sp. J Nat Prod (1994) 1.70
Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy. Lancet (1968) 1.67
Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis. Gut (1967) 1.67
Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut (1981) 1.67
The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology (1975) 1.66
Liver damage due to methotrexate in patients with psoriasis. Br Med J (1971) 1.62
Immunological studies in an epidemic of infective, short-incubation hepatitis. Lancet (1972) 1.62
Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis. J Cancer Res Clin Oncol (1986) 1.61
Thymus-dependent lymphocyte function in patients with hepatitis-associated antigen. Lancet (1972) 1.60
Renal and intrarenal blood-flow in cirrhosis of the liver. Lancet (1971) 1.60
Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet (1972) 1.59
Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut (1986) 1.58
Arsenic and noncirrhotic portal hypertension. Gastroenterology (1974) 1.57
Vitamin A treatment for night blindness in primary biliary cirrhosis. Br Med J (Clin Res Ed) (1984) 1.57
Palytoxin: a new marine toxin from a coelenterate. Science (1971) 1.56
Effect of neurotensin on gastric function in man. Lancet (1980) 1.55
Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients. J Hepatol (1986) 1.55
Liver biopsy in the diagnosis of cirrhosis. Gut (1970) 1.53
Percutaneous liver biopsy in patients with large bile duct obstruction. Gastroenterology (1975) 1.53
Angiosarcoma of the liver: annual occurrence and aetiology in Great Britain. Br J Ind Med (1980) 1.52
Chronic pancreatitis: a cause of cholestasis. Gut (1977) 1.51
Mitochondrial and other tissue antibodies in relatives of patients with primary biliary cirrhosis. Clin Exp Immunol (1972) 1.50
Halothane hepatitis. Lancet (1978) 1.50
Is mitochondrial antibody diagnostic of primary biliary cirrhosis? Gut (1981) 1.50
Studies in alcoholic liver disease in Britain. I. Clinical and pathological patterns related to natural history. Gut (1974) 1.50
Hepatocellular carcinoma arising in an adenoma: value of QBend 10 immunostaining in diagnosis of liver cell carcinoma. Histopathology (1996) 1.49
The pathology of diabetic hepatitis. J Pathol (1988) 1.48
Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). A study of 42 families. N Engl J Med (1967) 1.48
Hepatic reactions associated with ketoconazole in the United Kingdom. Br Med J (Clin Res Ed) (1987) 1.47
Treatment of ascites by continuous ultrafiltration and reinfusion of protein concentrate. Lancet (1974) 1.46
Diagnosis of primary cancer of the liver. Br Med J (1971) 1.45
D-penicillamine treatment improves survival in primary biliary cirrhosis. Lancet (1981) 1.45
Clinical diagnosis of the Budd-Chiari syndrome. A report of six cases. Am J Med (1967) 1.45
Immunoglobulin-containing cells in the liver. Clin Exp Immunol (1969) 1.44
Hepatobiliary changes in erythropoietic protoporphyria. Arch Pathol (1965) 1.43